News

news-preview-placeholder
Launch of Generic Equivalent: Crestor (Rosuvastatin)

The generic equivalent of Crestor (rosuvastatin) has just been released, following FDA approval. Crestor is…

May 03, 2016
news-preview-placeholder
Brand-name Vivlodex™ and Generic MOBIC

Vivlodex™ is a low-dose nonsteroidal anti-inflammatory drug (NSAID) new option for people suffering from the…

Apr 28, 2016
news-preview-placeholder
Georgia State Board of Workers’ Compensation Seminar

Carlisle Medical employees will be attending the Georgia State Board of Workers’ Compensation Seminar for…

Apr 20, 2016
news-preview-placeholder
Mississippi Workers’ Compensation Educational Conference (MWCEA)

The Mississippi Workers’ Compensation Educational Conference (MWCEA) will be held on April 15-17, 2016, at…

Apr 14, 2016
news-preview-placeholder
FCCI Insurance Group’s Annual Claims Vendor Showcase

The FCCI Insurance Group’s Annual Claims Vendor Showcase will be held April 7, 2016 at…

Apr 07, 2016
news-preview-placeholder
ASIA 2016 Spring Fling

The ASIA (Arkansas Self-Insurers Association) 2016 Spring Fling will be held April 5 – April…

Apr 05, 2016
news-preview-placeholder
Launch of Generic Voltaren 1% Gel

The generic equivalent of Voltaren 1% topical gel (diclofenac sodium) has just been released, following…

Mar 28, 2016
news-preview-placeholder
Launch of Generic Nasonex

The generic equivalent of Nasonex (mometasone) has just been released, following FDA approval. Nasonex is…

Mar 23, 2016
news-preview-placeholder
Launch of Generic Frova

The generic equivalent of Frova (frovatriptan succinate) has just been released, following FDA approval. Frova…

news-preview-placeholder
Launch of Generic Enablex

The generic equivalent of Enablex (darifenacin) has just been released, following FDA approval. Enablex is…

Mar 15, 2016
  • This field is for validation purposes and should be left unchanged.


Filter Articles

Should a claimant need this much pain medication for this long? Are claimants utilizing medications or selling on the black market?

The prevalence of opioid use and abuse among those with chronic pain has developed into one of the most pressing issues today. Download the white paper to learn facts about the opioid crisis and possible solutions to avoid prescriptions that could lead to abuse.

Download Now